Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH
VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 04/28/17

    • 30-Day SEC Yield1

      1.96%
    • Total Net Assets

      $305.8M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      06/30/2017
  • Portfolio Composition (%)
    as of 04/28/17

    • % of Net Assets
    • Stocks

      100.33
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.33
  • Download All HoldingsDaily Holdings (%) as of 04/28/17

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    217,200
    26,817,6848.77
    Novartis Ag
    NVS US
    241,718
    18,619,5386.09
    Sanofi
    SNY US
    352,776
    16,686,3055.46
    Pfizer Inc
    PFE US
    476,434
    16,160,6415.28
    Novo Nordisk A/S
    NVO US
    416,566
    16,112,7735.27
    Astrazeneca Plc
    AZN US
    519,032
    15,700,7185.13
    Abbvie Inc
    ABBV US
    237,989
    15,692,9955.13
    Glaxosmithkline Plc
    GSK US
    371,129
    15,179,1764.96
    Bristol-Myers Squibb Co
    BMY US
    267,240
    14,978,8024.90
    Zoetis Inc
    ZTS US
    259,212
    14,544,3854.76
    Merck & Co Inc
    MRK US
    231,986
    14,459,6874.73
    Shire Plc
    SHPG US
    77,175
    13,656,8884.47
    Eli Lilly & Co
    LLY US
    164,713
    13,516,3494.42
    Teva Pharmaceutical Industries Ltd
    TEVA US
    418,466
    13,215,1564.32
    Perrigo Co Plc
    PRGO US
    174,087
    12,871,9934.21
    Mckesson Corp
    MCK US
    92,936
    12,852,1194.20
    Amerisourcebergen Corp
    ABC US
    154,221
    12,653,8334.14
    Mylan Nv
    MYL US
    316,041
    11,804,1313.86
    Jazz Pharmaceuticals Plc
    JAZZ US
    55,091
    8,774,8942.87
    Mallinckrodt Plc
    MNK US
    112,729
    5,289,2451.73
    Valeant Pharmaceuticals International I
    VRX US
    456,225
    4,220,0811.38
    Patterson Cos Inc
    PDCO US
    94,055
    4,184,5071.37
    Akorn Inc
    AKRX US
    107,076
    3,581,6921.17
    Gw Pharmaceuticals Plc
    GWPH US
    27,117
    3,219,6011.05
    Endo International Plc
    ENDP US
    181,624
    2,065,0650.68
    Other/Cash
    --
    --
    -1,014,058-0.33
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.